Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NRX Pharmaceuticals (NASDAQ:NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
NRX Pharmaceuticals has a consensus price target of $29.57.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $2.6 last updated October 16, 2026 at 7:43 PM EDT.
There are no upcoming dividends for NRX Pharmaceuticals.
NRX Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.